|D018149||Glucose Intolerance NIH||0.58|
|D011236||Prediabetic State NIH||0.50|
|D024821||Metabolic Syndrome NIH||0.50|
There is one clinical trial.
DPPFit is a Healthy Lifestyle Intervention designed to reformat the effective strategies of the Diabetes Prevention Program (NDPP) into a tool for use in a primary care setting. DPPFit is a 16-week technology-based intervention for diabetes prevention. In keeping with the National DPP educational sessions, the intervention weeks follow the order and presentation of the N-DPP 16 session topics. The goal is to develop a pragmatic translation of the DPP that is effective in the real-world setting of primary care clinic. The hope is that in doing so, those at risk of developing type II diabetes mellitus will have evidenced-based prevention methods at their disposal.
Description: Weight Loss by % of Body Weight Loss, by # of Participants losing 5% and 7% of Body WeightMeasure: Weight Loss Time: 12 Months
Description: Increase in PA days/week, Increase > 10% of PA, Kcal/weekMeasure: Physical Activity Time: 6 months
Description: Decrease in Sedentary Time, Mins/dayMeasure: Inactivity Time: 6 months
Description: MOS SF-20 / MOS Social Support ScaleMeasure: Health Related Quality of Life Time: 6 months /
Description: Reduction in % of HbA1c at 1 year follow-upMeasure: Hemoglobin A1c Time: 12 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports